Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$56.27 - $73.77 $95,602 - $125,335
1,699 New
1,699 $117,000
Q2 2022

Aug 15, 2022

BUY
$35.61 - $76.23 $7,656 - $16,389
215 Added 59.56%
576 $23,000
Q1 2022

May 13, 2022

BUY
$57.56 - $82.54 $8,231 - $11,803
143 Added 65.6%
361 $25,000
Q4 2021

Feb 11, 2022

BUY
$72.5 - $100.68 $3,915 - $5,436
54 Added 32.93%
218 $17,000
Q3 2021

Feb 11, 2022

SELL
$90.24 - $124.05 $1,443 - $1,984
-16 Reduced 8.89%
164 $16,000
Q2 2021

Feb 11, 2022

BUY
$93.66 - $139.27 $6,368 - $9,470
68 Added 60.71%
180 $22,000
Q1 2021

Feb 08, 2022

BUY
$116.57 - $155.01 $13,055 - $17,361
112 New
112 $15,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track State Of Wyoming Portfolio

Follow State Of Wyoming and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.